202 related articles for article (PubMed ID: 1978710)
21. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.
Denning SM; Le PT; Singer KH; Haynes BF
J Immunol; 1990 Jan; 144(1):7-15. PubMed ID: 1967267
[TBL] [Abstract][Full Text] [Related]
22. Identification of a CD2- CD3+ T cell receptor-gamma+ peripheral blood lymphocyte subpopulation.
Faure F; Jitsukawa S; Meuer S; Bohuon C; Triebel F; Hercend T
J Immunol; 1988 Apr; 140(7):2128-32. PubMed ID: 2895149
[TBL] [Abstract][Full Text] [Related]
23. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
Yang SY; Rhee S; Welte K; Dupont B
J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
[TBL] [Abstract][Full Text] [Related]
24. Analysis of CD4 and CD2 receptor function.
Goldman SJ; Bierer BE; Burakoff SJ
Princess Takamatsu Symp; 1988; 19():149-60. PubMed ID: 2908352
[TBL] [Abstract][Full Text] [Related]
25. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.
Van Seventer GA; Van Lier RA; Kuijpers KC; Spits H; Melief CJ
Eur J Immunol; 1988 Dec; 18(12):1973-8. PubMed ID: 2905994
[TBL] [Abstract][Full Text] [Related]
26. Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions.
Suthanthiran M
Transplant Proc; 1987 Feb; 19(1 Pt 1):336-7. PubMed ID: 2908550
[No Abstract] [Full Text] [Related]
27. CD4+CD45R+ cells are preferentially activated through the CD2 pathway.
Matsuyama T; Anderson P; Daley JF; Schlossman S; Morimoto C
Eur J Immunol; 1988 Sep; 18(9):1473-6. PubMed ID: 2458944
[TBL] [Abstract][Full Text] [Related]
28. A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and natural killer cells.
Samstag Y; Bader A; Meuer SC
J Immunol; 1991 Aug; 147(3):788-94. PubMed ID: 1677669
[TBL] [Abstract][Full Text] [Related]
29. CD2 and CD3 antigens mobilize Ca2+ independently.
O'Flynn K; Knott LJ; Russul-Saib M; Abdul-Gaffar R; Morgan G; Beverley PC; Linch DC
Eur J Immunol; 1986 May; 16(5):580-4. PubMed ID: 3084290
[TBL] [Abstract][Full Text] [Related]
30. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor.
Bockenstedt LK; Goldsmith MA; Dustin M; Olive D; Springer TA; Weiss A
J Immunol; 1988 Sep; 141(6):1904-11. PubMed ID: 2459194
[TBL] [Abstract][Full Text] [Related]
31. Regulation of CD4 and CD8 surface expression on human thymocyte subpopulations by triggering through CD2 and the CD3-T cell receptor.
Blue ML; Daley JF; Levine H; Branton KR; Schlossman SF
J Immunol; 1989 Jan; 142(2):374-80. PubMed ID: 2783435
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
[TBL] [Abstract][Full Text] [Related]
33. Signaling via the T-cell antigen receptor heterodimer and the CD2 antigen: a novel, synergistic pathway for activation of T-cells.
Suthanthiran M
Transplant Proc; 1989 Feb; 21(1 Pt 1):340-1. PubMed ID: 2565053
[No Abstract] [Full Text] [Related]
34. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
[TBL] [Abstract][Full Text] [Related]
35. Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation.
Pierrès A; Lopez M; Cerdan C; Nunes J; Olive D; Mawas C
Eur J Immunol; 1988 May; 18(5):685-90. PubMed ID: 2454190
[TBL] [Abstract][Full Text] [Related]
36. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule.
Gerli R; Agea E; Muscat C; Ercolani R; Bistoni O; Tognellini R; Mariggió MA; Spinozzi F; Bertotto A
Cell Immunol; 1994 Apr; 155(1):205-18. PubMed ID: 7909498
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of a cDNA encoding a putative cytokine which is induced by stimulation via the CD2 structure on human T lymphocytes.
Chang HC; Reinherz EL
Eur J Immunol; 1989 Jun; 19(6):1045-51. PubMed ID: 2568930
[TBL] [Abstract][Full Text] [Related]
38. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria.
Schieferdecker HL; Ullrich R; Hirseland H; Zeitz M
J Immunol; 1992 Oct; 149(8):2816-22. PubMed ID: 1383328
[TBL] [Abstract][Full Text] [Related]
39. T-lymphocyte activation pathways in alcoholic liver disease.
Spinozzi F; Bertotto A; Rondoni F; Gerli R; Scalise F; Grignani F
Immunology; 1991 Jun; 73(2):140-6. PubMed ID: 1676985
[TBL] [Abstract][Full Text] [Related]
40. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.
Koulova L; Yang SY; Dupont B
J Immunol; 1990 Oct; 145(7):2035-43. PubMed ID: 1697875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
